NEW YORK ( TheStreet) -- Ariad Pharmaceuticals (Nasdaq: ARIA) hit a new 52-week high Monday as it is currently trading at $16.29, above its previous 52-week high of $15.98 with 435,987 shares traded as of 9:45 a.m. ET. Average volume has been 3.2 million shares over the past 30 days. Ariad has a market cap of $2.29 billion and is part of the health care sector and drugs industry. Shares are up 28.3% year to date as of the close of trading on Friday. ARIAD Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter